Annovis Bio, Inc.

Analysis for Ticker: ANVS

Annovis Bio, Inc is a biotechnology company that claims to be developing drugs for brain diseases like Alzheimer’s and Parkinson’s, but the financial reality is a machine designed to turn investor cash into thin air. The math is a total disaster because the company has piled up a lifetime loss of 163,7$ million and has never made a single penny in profit. It is like a piggy bank that only lets you put money in, but every time you do, the people holding the bank take a big scoop for themselves while telling you the bank is worth less than it was before. Instead of creating value, they are printing millions of new pieces of paper called shares to pay their bills, which makes every share you own smaller and smaller until the ownership is almost invisible.